Presentation Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation Presenter: A. Massumi January 14, 2013 REGISTER for free or LOG IN to view this content Left Atrial Appendage Factoid Up Next Presentation ENGAGE: Gender Differences Following EVAR Presenter: L. Dubois January 14, 2013 More slides + Presentation Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func Presenter: Andrew L. Frelinger January 15, 2013 Presentation Transcatheter Aortic Valve Implantation with the Edwards Sapien vs. Medtronic CoreValve Devices Presenter: A. Chieffo January 15, 2013 We Recommend
Presentation Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func Presenter: Andrew L. Frelinger January 15, 2013
Presentation Transcatheter Aortic Valve Implantation with the Edwards Sapien vs. Medtronic CoreValve Devices Presenter: A. Chieffo January 15, 2013